Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377010779> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4377010779 abstract "Abstract Objectives To evaluate whether addition of low-moderate dose prednisone to methotrexate (MTX) treatment can alleviate common MTX side-effects in rheumatoid arthritis (RA) patients. Methods We performed a post-hoc analysis of the CAMERA-II trial which randomized (1:1) 236 early DMARD and prednisone naive RA patients to treatment with MTX + prednisone 10 mg daily, or MTX monotherapy during two years. MTX dose was increased using a treat-to-target approach. We used Generalized Estimating Equations to model the occurrence of common MTX side-effects and of any adverse event over time, controlling for disease activity and MTX dose over time and other possible predictors of adverse events. To assess whether a possible effect was prednisone-specific, we performed the same analysis in the U-ACT-EARLY trial, in which the addition of tocilizumab (TCZ) to MTX was compared to MTX monotherapy in a comparable setting. Results MTX side-effects were reported at 5.9% of visits in the prednisone-MTX group, compared to 11.2% in the MTX monotherapy group. After controlling for MTX dose and disease activity over time, treatment duration, age, sex, and baseline transaminase levels, addition of prednisone significantly decreased the occurrence of MTX side-effects (OR: 0.54, CI: 0.38–0.77, p = 0.001). Specifically, the occurrence of nausea (OR 0.46, CI: 0.26–0.83, p = 0.009)) and elevated ALT/AST (OR 0.29, CI: 0.17–0.49, p < 0.001) was decreased. There was a trend towards fewer overall adverse events in the prednisone-MTX arm (OR: 0.89, CI: 0.72–1.11, p = 0.30). No difference in MTX side-effects was found between TCZ-MTX and MTX monotherapy in U-ACT-EARLY (OR 1.05, CI: 0.61–1.80, p = 0.87). Conclusion Addition of 10 mg prednisone daily to MTX treatment in RA patients may ameliorate MTX side-effects, specifically nausea and elevated ALT/AST." @default.
- W4377010779 created "2023-05-19" @default.
- W4377010779 creator A5039255500 @default.
- W4377010779 creator A5044386973 @default.
- W4377010779 creator A5073590530 @default.
- W4377010779 creator A5079577210 @default.
- W4377010779 date "2023-05-17" @default.
- W4377010779 modified "2023-10-10" @default.
- W4377010779 title "Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients" @default.
- W4377010779 cites W1953534612 @default.
- W4377010779 cites W1971770050 @default.
- W4377010779 cites W2013864512 @default.
- W4377010779 cites W2065913585 @default.
- W4377010779 cites W2066086852 @default.
- W4377010779 cites W2099272200 @default.
- W4377010779 cites W2120393706 @default.
- W4377010779 cites W2128447949 @default.
- W4377010779 cites W2133103918 @default.
- W4377010779 cites W2155195115 @default.
- W4377010779 cites W2408830150 @default.
- W4377010779 cites W2607858667 @default.
- W4377010779 cites W2783428982 @default.
- W4377010779 cites W2999159915 @default.
- W4377010779 cites W4231972505 @default.
- W4377010779 doi "https://doi.org/10.1186/s41927-023-00331-0" @default.
- W4377010779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37198659" @default.
- W4377010779 hasPublicationYear "2023" @default.
- W4377010779 type Work @default.
- W4377010779 citedByCount "0" @default.
- W4377010779 crossrefType "journal-article" @default.
- W4377010779 hasAuthorship W4377010779A5039255500 @default.
- W4377010779 hasAuthorship W4377010779A5044386973 @default.
- W4377010779 hasAuthorship W4377010779A5073590530 @default.
- W4377010779 hasAuthorship W4377010779A5079577210 @default.
- W4377010779 hasBestOaLocation W43770107791 @default.
- W4377010779 hasConcept C126322002 @default.
- W4377010779 hasConcept C197934379 @default.
- W4377010779 hasConcept C199360897 @default.
- W4377010779 hasConcept C2777077863 @default.
- W4377010779 hasConcept C2777575956 @default.
- W4377010779 hasConcept C2778720950 @default.
- W4377010779 hasConcept C2779384505 @default.
- W4377010779 hasConcept C2780580376 @default.
- W4377010779 hasConcept C2781059491 @default.
- W4377010779 hasConcept C3454156 @default.
- W4377010779 hasConcept C41008148 @default.
- W4377010779 hasConcept C71924100 @default.
- W4377010779 hasConcept C90924648 @default.
- W4377010779 hasConceptScore W4377010779C126322002 @default.
- W4377010779 hasConceptScore W4377010779C197934379 @default.
- W4377010779 hasConceptScore W4377010779C199360897 @default.
- W4377010779 hasConceptScore W4377010779C2777077863 @default.
- W4377010779 hasConceptScore W4377010779C2777575956 @default.
- W4377010779 hasConceptScore W4377010779C2778720950 @default.
- W4377010779 hasConceptScore W4377010779C2779384505 @default.
- W4377010779 hasConceptScore W4377010779C2780580376 @default.
- W4377010779 hasConceptScore W4377010779C2781059491 @default.
- W4377010779 hasConceptScore W4377010779C3454156 @default.
- W4377010779 hasConceptScore W4377010779C41008148 @default.
- W4377010779 hasConceptScore W4377010779C71924100 @default.
- W4377010779 hasConceptScore W4377010779C90924648 @default.
- W4377010779 hasIssue "1" @default.
- W4377010779 hasLocation W43770107791 @default.
- W4377010779 hasLocation W43770107792 @default.
- W4377010779 hasOpenAccess W4377010779 @default.
- W4377010779 hasPrimaryLocation W43770107791 @default.
- W4377010779 hasRelatedWork W1984142418 @default.
- W4377010779 hasRelatedWork W2153657596 @default.
- W4377010779 hasRelatedWork W2319807650 @default.
- W4377010779 hasRelatedWork W2352009657 @default.
- W4377010779 hasRelatedWork W2368117966 @default.
- W4377010779 hasRelatedWork W2475213414 @default.
- W4377010779 hasRelatedWork W2796944699 @default.
- W4377010779 hasRelatedWork W3127970713 @default.
- W4377010779 hasRelatedWork W4377010779 @default.
- W4377010779 hasRelatedWork W2185841895 @default.
- W4377010779 hasVolume "7" @default.
- W4377010779 isParatext "false" @default.
- W4377010779 isRetracted "false" @default.
- W4377010779 workType "article" @default.